# OnCo record ala-105 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ala-105/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ala-105" ;
  schema:name "ALA-105"@en ;
  schema:alternateName "CLDN18.2-iNKT"@en ;
  schema:description "ALA-105 is an experimental CAR-iNKT cell therapy with IL-12 armouring from Arovella Therapeutics, at a stage the company does not state for gastric cancer, gastro-oesophageal junction cancer and pancreatic cancer."@en ;
  schema:url <https://onco.cc/drugs/ala-105/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.arovella.com/ala-105-cldn182-inkt>, <https://www.arovella.com/ala-105-cldn182-inkt> ;
  onco:tag "pipeline" ;
  onco:modality "CAR-iNKT cell therapy with IL-12 armouring" ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:companies <https://onco.cc/companies/arovella-therapeutics/> .